J Herson|S K Carter - JoVE Visualize

Showing results (81-90 of 89) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 89 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programsJ R Daniels, L Y Chak, B I Sikic, et al.

Annals of Internal Medicine|December 1, 1983

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsyF M Torti, M R Bristow, A E Howes, et al.

Cancer Research|October 1, 1983

Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazoleC N Coleman, M K Friedman, C Jacobs, et al.

Cancer|December 1, 1985

A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinomaF M Torti, L D Shortliffe, S K Carter, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trialK K Fu, T L Phillips, I J Silverberg, et al.

Cancer Treatment Reports|March 1, 1977

Characterization of prostatic carcinoma among blacks: a continuation reportM A Jackson, B S Ahluwalia, J Herson, et al.

Cancer Research|July 1, 1986

Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsyF M Torti, M M Bristow, B L Lum, et al.

Cancer Chemotherapy Reports|January 1, 1975

Characterization of prostatic carcinoma among blacks: a preliminary reportM A Jackson, B S Ahluwalia, E B Attah, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 16, 2000

Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activityW Shakespeare, M Yang, R Bohacek, et al.

Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 89 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programsJ R Daniels, L Y Chak, B I Sikic, et al.

Annals of Internal Medicine|December 1, 1983

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsyF M Torti, M R Bristow, A E Howes, et al.

Cancer Research|October 1, 1983

Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazoleC N Coleman, M K Friedman, C Jacobs, et al.

Cancer|December 1, 1985

A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinomaF M Torti, L D Shortliffe, S K Carter, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trialK K Fu, T L Phillips, I J Silverberg, et al.

Cancer Treatment Reports|March 1, 1977

Characterization of prostatic carcinoma among blacks: a continuation reportM A Jackson, B S Ahluwalia, J Herson, et al.

Cancer Research|July 1, 1986

Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsyF M Torti, M M Bristow, B L Lum, et al.

Cancer Chemotherapy Reports|January 1, 1975

Characterization of prostatic carcinoma among blacks: a preliminary reportM A Jackson, B S Ahluwalia, E B Attah, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 16, 2000

Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activityW Shakespeare, M Yang, R Bohacek, et al.

Pageof 9